Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- ["TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race](
[Get the full story on this new North American graphite opportunity]( --------------------------------------------------------------- December 14, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Will This Jumpstart a New Uranium Boom Market?](
in the early 2000's, Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars. Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with a strong comeback for nuclear energy, this could be setting the stage for the next uranium boom. [Get the Full Story on Uranium Opportunities Here](
--------------------------------------------------------------- [Arcellx Inc, ACLX]( Recent Analyst Action: Jason Gerberry, analyst at Bank of America Securities, reiterates coverage on [Arcellx Inc (ACLX)](in the Healthcare sector with a Buy rating and a price target of $37.00 (1 day ago). - Recent Price: $31.18
- Average Analyst Price Target: $35.83 (14.91%)
- Market Cap: $1.38B [TipRanks.com]( also reports that [Arcellx Inc](currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $35.83. The target pricing ranges from a high forecast of $38.00 down to a low forecast of $34.00. [Arcellx Inc (ACLX)](’s last closing price was $31.18 which would put the average price target at $35.83. Here are 3rd party ratings for [ACLX](: - TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 23% (57 out of 248) [Click here for chart >>]( --------------------------------------------------------------------------
--------------------------------------------------------------- [Is America Back to "Normal"?]( Do you believe America’s economic fallout from 2020 has been fixed? Do you think things could get worse? If you are concerned about these possibilities, you are not alone. Expert who predicted Black Monday and the dot-com crash issues new important message.
--------------------------------------------------------------- [Fluence Energy, FLNC]( Recent Analyst Action: Ben Kallo, analyst at Robert W. Baird, reiterates coverage on [Fluence Energy (FLNC)](in the Industrial Goods sector with a Buy rating and a price target of $27.00 (10 hours ago). - Recent Price: $21.9
- Average Analyst Price Target: $20.00 (0.46%)
- Market Cap: $3.76B [TipRanks.com]( also reports that [Fluence Energy](currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.00. The target pricing ranges from a high forecast of $25.00 down to a low forecast of $13.00. [Fluence Energy (FLNC)](’s last closing price was $21.9 which would put the average price target at $22.00. Here are 3rd party ratings for [FLNC](: - TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Bottom 39% (152 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [DocuSign, DOCU]( Recent Analyst Action: Tyler Radke, analyst at Citigroup, reiterates coverage on [DocuSign (DOCU)](in the Technology sector with a Buy rating and a price target of $72.00 (2 days ago). - Recent Price: $60.82
- Average Analyst Price Target: $56.20 (-7.60%)
- Market Cap: $11.67B [TipRanks.com]( also reports that [DocuSign](currently has 18 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $56.20. The target pricing ranges from a high forecast of $84.00 down to a low forecast of $38.00. [DocuSign (DOCU)](’s last closing price was $60.82 which would put the average price target at $56.20. Here are 3rd party ratings for [DOCU](: - TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Buy, Bottom 43% (141 out of 248) [Click here for chart >>]( --------------------------------------------------------------------------
--------------------------------------------------------------- [These 2 Dividend Stocks Pay Every Week]( you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.](
--------------------------------------------------------------- [Rapid7, RPD]( Recent Analyst Action: Gregg Moskowitz, analyst at Mizuho Securities, reiterates coverage on [Rapid7 (RPD)](in the Technology sector with a Hold rating and a price target of $40.00 (6 days ago). - Recent Price: $37.93
- Average Analyst Price Target: $46.64 (22.96%)
- Market Cap: $2.21B [TipRanks.com]( also reports that [Rapid7](currently has 16 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $46.64. The target pricing ranges from a high forecast of $58.00 down to a low forecast of $30.00. [Rapid7 (RPD)](’s last closing price was $37.93 which would put the average price target at $46.64. Here are 3rd party ratings for [RPD](: - TipRanks.com: Moderate Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 23% (57 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Datadog, DDOG]( Recent Analyst Action: Ittai Kidron, analyst at Oppenheimer, reiterates coverage on [Datadog (DDOG)](in the Technology sector with a Buy rating and a price target of $105.00 (10 hours ago). - Recent Price: $82.33
- Average Analyst Price Target: $110.26 (33.66%)
- Market Cap: $25.31B [TipRanks.com]( also reports that [Datadog](currently has 26 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $110.26. The target pricing ranges from a high forecast of $162.00 down to a low forecast of $82.00. [Datadog (DDOG)](’s last closing price was $82.33 which would put the average price target at $110.04. Here are 3rd party ratings for [DDOG](: - TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Buy, Top 23% (57 out of 248) [Click here for chart >>]( --------------------------------------------------------------------------
--------------------------------------------------------------- [Are Investors Returning to the Small-Cap Uranium Sector?](
in the early 2000's, small-cap Paladin Energy was the darling of the last uranium boom when it shot up from ten cents to over nine dollars. Today's uranium supply/demand imbalance has a lot in common with the last market cycle. Combined with the energy crisis and "green revolution," this could be setting the stage for the next uranium boom. [Get the Full Story on Uranium Opportunities Here](
--------------------------------------------------------------- [Cassava Sciences, SAVA]( Recent Analyst Action: James Jang, analyst at Univest Securities, reiterates coverage on [Cassava Sciences (SAVA)](in the Healthcare sector with a Sell rating and a price target of $11.00 (2 weeks ago). - Recent Price: $43.59
- Average Analyst Price Target: $69.75 (60.01%)
- Market Cap: $1.84B [TipRanks.com]( also reports that [Cassava Sciences](currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $69.75. The target pricing ranges from a high forecast of $124.00 down to a low forecast of $11.00. [Cassava Sciences (SAVA)](’s last closing price was $43.59 which would put the average price target at $69.75. Here are 3rd party ratings for [SAVA](: - TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 35% (87 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Varonis Systems, VRNS]( Recent Analyst Action: Shaul Eyal, analyst at Cowen & Co., reiterates coverage on [Varonis Systems (VRNS)](in the Technology sector with a Buy rating and a price target of $35.00 (1 month ago). - Recent Price: $24.36
- Average Analyst Price Target: $28.60 (17.41%)
- Market Cap: $2.65B [TipRanks.com]( also reports that [Varonis Systems](currently has 16 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $28.60. The target pricing ranges from a high forecast of $63.00 down to a low forecast of $20.00. [Varonis Systems (VRNS)](’s last closing price was $24.36 which would put the average price target at $28.60. Here are 3rd party ratings for [VRNS](: - TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 28% (69 out of 248) [Click here for chart >>]( --------------------------------------------------------------------------
--------------------------------------------------------------- [Military Defense Impacted by Domestic Uranium Shortage?](
people know that the U.S. military's nuclear fleet is the largest uranium fuel consumer in the world. About 160 U.S. ships are powered by over 200 small nuclear reactors. While most are submarines, some icebreakers and aircraft carriers are also nuclear-powered. Unfortunately, current U.S. reliance on Russian state-owned sources for our uranium supply leaves our entire nuclear energy sector - including defense - vulnerable to geopolitical conflict such as Russia's war against Ukraine. [See the Factors Creating New Uranium Investment Opportunities](
--------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely,
The Editor, MarketTickerPress.com Market Ticker Press Disclaimer
This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security.
We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice.
The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances.
Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled.
Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate.
Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research.
Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results.
Always consult a real licensed investment professional before making any investment decision.
Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software